Results 271 to 280 of about 19,068,215 (411)

Hemoadsorption in cardiac surgery, limitations of low-risk patient selection and minimal cytokine levels. [PDF]

Crit Care
Ramírez-Guerrero G, Pedreros-Rosales C.
europepmc   +1 more source

Seminal vesicle biopsy and laparoscopic pelvic lymph node dissections implications for patient selection in the radiotherapeutic management of prostate cancer

, 1994
Nelsnn Stone, Richard G. Stock, Pam Unger   +2 more
openalex   +1 more source

Patient Selection for Endovascular Abdominal Aortic Aneurysm Repair [PDF]

, 2001
Richard M. Green
openalex   +1 more source

Virtual stent graft deployment as an aid in patient-specific selection and sizing [PDF]

, 2013
De Beule, Matthieu, De Bock, Sander, Iannaccone, Francesco, Segers, Patrick, Verhegghe, Benedict, Vermassen, Frank   +5 more
core   +1 more source

Inhibitor of DNA binding‐1 is a key regulator of cancer cell vasculogenic mimicry

Molecular Oncology, EarlyView.
Elevated expression of transcriptional regulator inhibitor of DNA binding 1 (ID1) promoted cancer cell‐mediated vasculogenic mimicry (VM) through regulation of pro‐angiogenic and pro‐cancerous genes (e.g. VE‐cadherin (CDH5), TIE2, MMP9, DKK1). Higher ID1 expression also increased metastases to the lung and the liver.
Emma J. Thompson, Emma L. Dorward, Kristyn Jurrius, Nathalie Nataren, Markus Tondl, Kay K. Myo Min, Michaelia P. Cockshell, Anahita Fouladzadeh, John Toubia, Mark DeNichilo, Delphine Merino, Claudine S. Bonder   +11 more
wiley   +1 more source

Clinical Use of Dostarlimab in Advanced Stage and Recurrent Endometrial Cancer: Patient Selection and Perspectives. [PDF]

Cancer Manag Res
Bujnak AC, File B, Tewari KS.
europepmc   +1 more source

MET and NF2 alterations confer primary and early resistance to first‐line alectinib treatment in ALK‐positive non‐small‐cell lung cancer

Molecular Oncology, EarlyView.
Alectinib resistance in ALK+ NSCLC depends on treatment sequence and EML4‐ALK variants. Variant 1 exhibited off‐target resistance after first‐line treatment, while variant 3 and later lines favored on‐target mutations. Early resistance involved off‐target alterations, like MET and NF2, while on‐target mutations emerged with prolonged therapy.
Jie Hu, Ning Ding, Xiaobo Xu, Yedan Chen, Yong Zhang, Jingwen Liu, Jiebai Zhou, Hairong Bao, Donghui Zhang, Yijun Song, Yang Shao, Yuanlin Song   +11 more
wiley   +1 more source

Patient Selection for Deep Brain Stimulation for Pantothenate Kinase-Associated Neurodegeneration. [PDF]

Tremor Other Hyperkinet Mov (N Y)
Chan JL, Rawls AE, Wong JK, Hogarth P, Hilliard JD, Okun MS.   +5 more
europepmc   +1 more source

Analysis of deaths in patients awaiting heart transplantation: impact on patient selection criteria.

, 1996
Guy A. Haywood, Peter Rickenbacher, Pedro T. Trindade, Lars Gullestad, Jeffrey Jiang, John S. Schroeder, Randall H. Vagelos, P E Oyer, Michael B. Fowler   +8 more
openalex   +1 more source

Liver Transplantation: Evolving Patient Selection Criteria [PDF]

, 2001
Andy Yu, Aijaz Ahmed, Emmet B. Keeffe
openalex   +1 more source